Hindustan Organic Chemicals Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 7, 2025, 8:11 pm

Market Cap	180 Cr.
Current Price	26.8
High / Low	62.7/22.4
Stock P/E
Book Value	14.6
Dividend Yield	0.00 %
ROCE	1.15 %
ROE	%
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Hindustan Organic Chemicals Ltd

Competitors of Hindustan Organic Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Hindustan Organic Chemicals Ltd	180 Cr.	26.8	62.7/22.4		14.6	0.00 %	1.15 %	%	10.0
Vinati Organics Ltd	16,739 Cr.	1,615	2,331/1,462	42.7	249	0.43 %	18.5 %	13.8 %	1.00
Seya Industries Ltd	49.0 Cr.	18.5	38.8/18.4		311	0.00 %	0.32 %	0.42 %	10.0
Industry Average	8,459.50 Cr	553.43		42.70	191.53	0.14%	6.66%	7.11%	7.00

All Competitor Stocks of Hindustan Organic Chemicals Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	102	196	124	139	174	194	145	189	187	183	59	175	165
Expenses	112	172	125	157	173	177	154	177	190	183	83	175	191
Operating Profit	-10	25	-1	-17	1	16	-9	11	-3	-1	-24	0	-26
OPM %	-10%	13%	-1%	-12%	1%	8%	-6%	6%	-2%	-0%	-40%	0%	-16%
Other Income	2	26	2	9	3	-5	3	5	4	7	5	5	-35
Interest	13	18	16	13	17	17	17	17	18	17	16	18	18
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit before tax	-21	32	-15	-21	-14	-6	-23	-2	-18	-12	-35	-14	-79
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-21	32	-15	-21	-14	-6	-23	-2	-18	-12	-35	-14	-79
EPS in Rs	-3.06	5.04	-2.15	-3.12	-2.01	-0.63	-3.44	-0.21	-2.65	-1.77	-5.27	-2.03	-11.76

Last Updated: February 28, 2025, 11:32 am

Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹165.00 Cr.. The value appears to be declining and may need further review. It has decreased from 175.00 Cr. (Sep 2024) to ₹165.00 Cr., marking a decrease of 10.00 Cr..
For Expenses, as of Dec 2024, the value is ₹191.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 175.00 Cr. (Sep 2024) to ₹191.00 Cr., marking an increase of ₹16.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹-26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Sep 2024) to ₹-26.00 Cr., marking a decrease of 26.00 Cr..
For OPM %, as of Dec 2024, the value is -16.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Sep 2024) to -16.00%, marking a decrease of 16.00%.
For Other Income, as of Dec 2024, the value is ₹-35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Sep 2024) to ₹-35.00 Cr., marking a decrease of 40.00 Cr..
For Interest, as of Dec 2024, the value is ₹18.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 18.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹-79.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Sep 2024) to ₹-79.00 Cr., marking a decrease of 65.00 Cr..
For Tax %, as of Dec 2024, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00%.
For Net Profit, as of Dec 2024, the value is ₹-79.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Sep 2024) to ₹-79.00 Cr., marking a decrease of 65.00 Cr..
For EPS in Rs, as of Dec 2024, the value is -11.76. The value appears to be declining and may need further review. It has decreased from ₹-2.03 (Sep 2024) to -11.76, marking a decrease of ₹9.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 28, 2025, 4:11 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	236	178	143	176	275	503	325	407	434	631	704	582
Expenses	382	306	265	335	442	475	384	381	433	625	705	632
Operating Profit	-146	-129	-121	-159	-167	28	-58	27	1	6	-1	-50
OPM %	-62%	-72%	-85%	-90%	-61%	6%	-18%	7%	0%	1%	-0%	-9%
Other Income	6	-26	15	6	63	117	21	21	34	6	18	-18
Interest	43	53	69	98	78	68	58	54	66	67	70	70
Depreciation	19	10	10	9	6	3	3	3	1	1	1	2
Profit before tax	-202	-217	-185	-259	-187	73	-98	-8	-32	-55	-54	-140
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-202	-217	-185	-259	-187	73	-98	-8	-32	-55	-54	-140
EPS in Rs	-28.41	-32.07	-26.82	-38.37	-27.79	10.79	-14.33	0.38	-4.41	-7.95	-8.13	-20.83
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-7.43%	14.75%	-40.00%	27.80%	139.04%	-234.25%	91.84%	-300.00%	-71.88%	1.82%
Change in YoY Net Profit Growth (%)	0.00%	22.17%	-54.75%	67.80%	111.24%	-373.28%	326.08%	-391.84%	228.12%	73.69%

Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	12%
5 Years:	7%
3 Years:	20%
TTM:	-19%

Compounded Profit Growth
10 Years:	5%
5 Years:	%
3 Years:	%
TTM:	-120%

Stock Price CAGR
10 Years:	6%
5 Years:	20%
3 Years:	-5%
1 Year:	-43%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 1:33 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	67	67	67	67	67	67	67	67	67	67	67	67
Reserves	-707	-933	-1,121	52	-33	44	-50	-36	-72	-118	-119	-165
Borrowings	556	698	703	603	609	606	521	518	1,226	1,286	1,362	870
Other Liabilities	412	459	584	1,103	1,018	837	841	895	258	242	264	806
Total Liabilities	329	292	234	1,825	1,662	1,555	1,379	1,444	1,479	1,478	1,575	1,578
Fixed Assets	151	137	125	1,689	154	170	174	136	155	165	226	231
CWIP	38	11	4	4	-0	-0	-0	-0	-0	-0	-0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	3
Other Assets	140	143	104	131	1,508	1,384	1,204	1,309	1,324	1,313	1,349	1,344
Total Assets	329	292	234	1,825	1,662	1,555	1,379	1,444	1,479	1,478	1,575	1,578

Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹67.00 Cr..
For Reserves, as of Sep 2024, the value is ₹-165.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from ₹-119.00 Cr. (Mar 2024) to ₹-165.00 Cr., marking a decline of 46.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹870.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from ₹1,362.00 Cr. (Mar 2024) to ₹870.00 Cr., marking a decrease of 492.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹806.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹264.00 Cr. (Mar 2024) to ₹806.00 Cr., marking an increase of 542.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹1,578.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,575.00 Cr. (Mar 2024) to ₹1,578.00 Cr., marking an increase of 3.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹231.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹226.00 Cr. (Mar 2024) to ₹231.00 Cr., marking an increase of 5.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Investments, as of Sep 2024, the value is ₹3.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹0.00 Cr. (Mar 2024) to ₹3.00 Cr., marking an increase of 3.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹1,344.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,349.00 Cr. (Mar 2024) to ₹1,344.00 Cr., marking a decrease of 5.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹1,578.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,575.00 Cr. (Mar 2024) to ₹1,578.00 Cr., marking an increase of 3.00 Cr..

However, the Borrowings (870.00 Cr.) are higher than the Reserves (₹-165.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-13	-116	46	59	-451	-160	-81	-50	10	-13	-66
Cash from Investing Activity +	11	0	-6	-0	343	112	164	8	11	7	56
Cash from Financing Activity +	3	104	-48	-59	179	3	-90	52	-32	-10	6
Net Cash Flow	-0	-12	-8	0	72	-45	-8	9	-11	-16	-4

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-702.00	-827.00	-824.00	-762.00	-776.00	-578.00	-579.00	-491.00	0.00	5.00	-2.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	18	51	22	19	11	17	14	3	7	11	10
Inventory Days	150	208	230	319	176	74	95	103	111	44	53
Days Payable	317	406	733	941	477	133	66	30	58	34	50
Cash Conversion Cycle	-149	-146	-481	-604	-291	-43	43	76	60	21	13
Working Capital Days	-414	-626	-1,197	-2,076	691	434	387	307	551	311	232
ROCE %				-91%	-17%	16%	-7%	9%	4%	1%	1%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%	58.78%
DIIs	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Public	41.21%	41.21%	41.21%	41.20%	41.22%	41.20%	41.19%	41.22%	41.20%	41.22%	41.20%	41.21%
No. of Shareholders	49,128	49,079	48,419	48,265	47,994	47,628	47,229	49,503	53,784	56,879	60,134	59,953

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	-8.05	-8.24	-4.37	-1.31	-14.55
Diluted EPS (Rs.)	-8.05	-8.24	-4.37	-1.31	-14.55
Cash EPS (Rs.)	-7.83	-8.05	-4.19	-0.87	-14.12
Book Value[Excl.RevalReserv]/Share (Rs.)	-13.00	-12.77	-5.38	-0.10	-0.12
Book Value[Incl.RevalReserv]/Share (Rs.)	-13.00	-12.77	-5.38	-0.10	-0.12
Revenue From Operations / Share (Rs.)	104.64	93.87	64.47	61.70	49.26
PBDIT / Share (Rs.)	2.33	1.90	3.45	7.10	-5.55
PBIT / Share (Rs.)	2.12	1.72	3.28	6.67	-5.96
PBT / Share (Rs.)	-8.22	-8.23	-4.37	-1.30	-14.53
Net Profit / Share (Rs.)	-8.04	-8.23	-4.37	-1.30	-14.53
NP After MI And SOA / Share (Rs.)	-8.12	-7.89	-3.97	-1.61	-14.29
PBDIT Margin (%)	2.22	2.02	5.35	11.50	-11.27
PBIT Margin (%)	2.02	1.83	5.08	10.80	-12.10
PBT Margin (%)	-7.85	-8.76	-6.77	-2.11	-29.49
Net Profit Margin (%)	-7.68	-8.76	-6.77	-2.11	-29.49
NP After MI And SOA Margin (%)	-7.76	-8.41	-6.15	-2.60	-29.02
Return on Networth / Equity (%)	0.00	0.00	0.00	-34.97	-486.30
Return on Capital Employeed (%)	14.22	11.03	13.99	16.73	-11.42
Return On Assets (%)	-3.47	-3.56	-1.81	-0.75	-6.99
Long Term Debt / Equity (X)	-0.04	0.00	0.00	2.49	8.03
Total Debt / Equity (X)	-16.20	-16.51	-197.52	13.60	21.94
Asset Turnover Ratio (%)	0.45	0.42	0.29	0.29	0.20
Current Ratio (X)	0.91	0.95	0.99	1.11	1.17
Quick Ratio (X)	0.86	0.91	0.94	1.06	1.12
Inventory Turnover Ratio (X)	8.48	6.77	4.34	3.97	3.97
Interest Coverage Ratio (X)	0.22	0.19	0.45	0.89	-0.64
Interest Coverage Ratio (Post Tax) (X)	0.20	0.17	0.42	0.83	-0.69
Enterprise Value (Cr.)	807.36	730.02	377.91	507.33	376.45
EV / Net Operating Revenue (X)	1.15	1.16	0.87	1.22	1.14
EV / EBITDA (X)	51.44	57.21	16.27	10.63	-10.08
MarketCap / Net Operating Revenue (X)	0.37	0.23	0.43	0.64	0.20
Price / BV (X)	-5.13	-3.05	-102.76	8.62	3.38
Price / Net Operating Revenue (X)	0.37	0.23	0.43	0.64	0.20
EarningsYield	-0.20	-0.35	-0.14	-0.04	-1.44

After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is -8.05. This value is below the healthy minimum of 5. It has increased from -8.24 (Mar 23) to -8.05, marking an increase of 0.19.
For Diluted EPS (Rs.), as of Mar 24, the value is -8.05. This value is below the healthy minimum of 5. It has increased from -8.24 (Mar 23) to -8.05, marking an increase of 0.19.
For Cash EPS (Rs.), as of Mar 24, the value is -7.83. This value is below the healthy minimum of 3. It has increased from -8.05 (Mar 23) to -7.83, marking an increase of 0.22.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -13.00. It has decreased from -12.77 (Mar 23) to -13.00, marking a decrease of 0.23.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is -13.00. It has decreased from -12.77 (Mar 23) to -13.00, marking a decrease of 0.23.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 104.64. It has increased from 93.87 (Mar 23) to 104.64, marking an increase of 10.77.
For PBDIT / Share (Rs.), as of Mar 24, the value is 2.33. This value is within the healthy range. It has increased from 1.90 (Mar 23) to 2.33, marking an increase of 0.43.
For PBIT / Share (Rs.), as of Mar 24, the value is 2.12. This value is within the healthy range. It has increased from 1.72 (Mar 23) to 2.12, marking an increase of 0.40.
For PBT / Share (Rs.), as of Mar 24, the value is -8.22. This value is below the healthy minimum of 0. It has increased from -8.23 (Mar 23) to -8.22, marking an increase of 0.01.
For Net Profit / Share (Rs.), as of Mar 24, the value is -8.04. This value is below the healthy minimum of 2. It has increased from -8.23 (Mar 23) to -8.04, marking an increase of 0.19.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -8.12. This value is below the healthy minimum of 2. It has decreased from -7.89 (Mar 23) to -8.12, marking a decrease of 0.23.
For PBDIT Margin (%), as of Mar 24, the value is 2.22. This value is below the healthy minimum of 10. It has increased from 2.02 (Mar 23) to 2.22, marking an increase of 0.20.
For PBIT Margin (%), as of Mar 24, the value is 2.02. This value is below the healthy minimum of 10. It has increased from 1.83 (Mar 23) to 2.02, marking an increase of 0.19.
For PBT Margin (%), as of Mar 24, the value is -7.85. This value is below the healthy minimum of 10. It has increased from -8.76 (Mar 23) to -7.85, marking an increase of 0.91.
For Net Profit Margin (%), as of Mar 24, the value is -7.68. This value is below the healthy minimum of 5. It has increased from -8.76 (Mar 23) to -7.68, marking an increase of 1.08.
For NP After MI And SOA Margin (%), as of Mar 24, the value is -7.76. This value is below the healthy minimum of 8. It has increased from -8.41 (Mar 23) to -7.76, marking an increase of 0.65.
For Return on Networth / Equity (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Return on Capital Employeed (%), as of Mar 24, the value is 14.22. This value is within the healthy range. It has increased from 11.03 (Mar 23) to 14.22, marking an increase of 3.19.
For Return On Assets (%), as of Mar 24, the value is -3.47. This value is below the healthy minimum of 5. It has increased from -3.56 (Mar 23) to -3.47, marking an increase of 0.09.
For Long Term Debt / Equity (X), as of Mar 24, the value is -0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.00 (Mar 23) to -0.04, marking a decrease of 0.04.
For Total Debt / Equity (X), as of Mar 24, the value is -16.20. This value is within the healthy range. It has increased from -16.51 (Mar 23) to -16.20, marking an increase of 0.31.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.45. It has increased from 0.42 (Mar 23) to 0.45, marking an increase of 0.03.
For Current Ratio (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1.5. It has decreased from 0.95 (Mar 23) to 0.91, marking a decrease of 0.04.
For Quick Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 23) to 0.86, marking a decrease of 0.05.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 8.48. This value exceeds the healthy maximum of 8. It has increased from 6.77 (Mar 23) to 8.48, marking an increase of 1.71.
For Interest Coverage Ratio (X), as of Mar 24, the value is 0.22. This value is below the healthy minimum of 3. It has increased from 0.19 (Mar 23) to 0.22, marking an increase of 0.03.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.20. This value is below the healthy minimum of 3. It has increased from 0.17 (Mar 23) to 0.20, marking an increase of 0.03.
For Enterprise Value (Cr.), as of Mar 24, the value is 807.36. It has increased from 730.02 (Mar 23) to 807.36, marking an increase of 77.34.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.15. This value is within the healthy range. It has decreased from 1.16 (Mar 23) to 1.15, marking a decrease of 0.01.
For EV / EBITDA (X), as of Mar 24, the value is 51.44. This value exceeds the healthy maximum of 15. It has decreased from 57.21 (Mar 23) to 51.44, marking a decrease of 5.77.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.37, marking an increase of 0.14.
For Price / BV (X), as of Mar 24, the value is -5.13. This value is below the healthy minimum of 1. It has decreased from -3.05 (Mar 23) to -5.13, marking a decrease of 2.08.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.37, marking an increase of 0.14.
For EarningsYield, as of Mar 24, the value is -0.20. This value is below the healthy minimum of 5. It has increased from -0.35 (Mar 23) to -0.20, marking an increase of 0.15.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Hindustan Organic Chemicals Ltd as of March 10, 2025 is: ₹26.81

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2025, Hindustan Organic Chemicals Ltd is Undervalued by 0.04% compared to the current share price 26.80

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Intrinsic Value of Hindustan Organic Chemicals Ltd as of March 10, 2025 is: 14.42

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2025, Hindustan Organic Chemicals Ltd is Overvalued by 46.19% compared to the current share price 26.80

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Last 5 Year EPS CAGR: -46.21%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Cash Conversion Cycle of -136.45, which is a positive sign.	The stock has a low average ROCE of -7.64%, which may not be favorable. The stock has a high average Working Capital Days of 170.00, which may not be favorable. The company has higher borrowings (796.50) compared to reserves (-271.50), which may suggest financial risk. The company has not shown consistent growth in sales (382.83) and profit (-113.67).

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
1. Net Profit Margin: -7.68%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 14.22% (Industry Average ROCE: 6.66%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 0% (Industry Average ROE: 7.11%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 0.2
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.86
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 42.7)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: -16.2
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Hindustan Organic Chemicals Ltd. is a Public Limited Listed company incorporated on 12/12/1960 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L99999KL1960GOI082753 and registration number is 082753. Currently company belongs to the Industry of Chemicals - Organic - Benzene Based. Company's Total Operating Revenue is Rs. 703.89 Cr. and Equity Capital is Rs. 67.27 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Benzene Based	Ambalamugal PO, Kunnathnad, Ernakulam Kerala 682302	cs@hoclindia.com www.hoclindia.com

Management
Name	Position Held
Mr. B Sanjeev	Chairman & Managing Director
Mr. Yogendra Prasad Shukla	Director - Finance
Mr. Kanishk Kant Srivastava	Government Nominee Director
Dr. Bharat J Kanabar	Non Official Independent Director
Mr. Pratyush Mandal	Non Official Independent Director
Mr. Manoj Sethi	Government Nominee Director

FAQ

What is the latest intrinsic value of Hindustan Organic Chemicals Ltd?

The latest intrinsic value of Hindustan Organic Chemicals Ltd as on 10 March 2025 is ₹26.81, which is 0.04% higher than the current market price of 26.80, indicating the stock is undervalued by 0.04%. The intrinsic value of Hindustan Organic Chemicals Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹180 Cr. and recorded a high/low of ₹62.7/22.4 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹-165 Cr and total liabilities of ₹1,578 Cr.

What is the Market Cap of Hindustan Organic Chemicals Ltd?

The Market Cap of Hindustan Organic Chemicals Ltd is 180 Cr..

What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 10 March 2025?

The current stock price of Hindustan Organic Chemicals Ltd as on 10 March 2025 is ₹26.8.

What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Hindustan Organic Chemicals Ltd stocks is ₹62.7/22.4.

What is the Stock P/E of Hindustan Organic Chemicals Ltd?

The Stock P/E of Hindustan Organic Chemicals Ltd is .

What is the Book Value of Hindustan Organic Chemicals Ltd?

The Book Value of Hindustan Organic Chemicals Ltd is 14.6.

What is the Dividend Yield of Hindustan Organic Chemicals Ltd?

The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.

What is the ROCE of Hindustan Organic Chemicals Ltd?

The ROCE of Hindustan Organic Chemicals Ltd is 1.15 %.

What is the ROE of Hindustan Organic Chemicals Ltd?

The ROE of Hindustan Organic Chemicals Ltd is %.

What is the Face Value of Hindustan Organic Chemicals Ltd?

The Face Value of Hindustan Organic Chemicals Ltd is 10.0.